Effect of High-Dose Quadrivalent Influenza Vaccine (Efluelda®) Versus Standard-Dose (QIV-SD), in Subjects 65 Years of Age and Older on Innate Immunity, Including Gene Expression

NCT05154383 · clinicaltrials.gov ↗

PHASE4

Phase

COMPLETED

Status

60

Enrollment

OTHER

Sponsor class

Conditions

Vaccine Reaction

Interventions

BIOLOGICAL: Experimental arm : High-Dose Quadrivalent Influenza Vaccine (Efluelda)
BIOLOGICAL: Active Comparator: Standard-Dose Quadrivalent Influenza Vaccine

Sponsor

Centre Hospitalier Annecy Genevois

Collaborators

[object Object]
[object Object]
[object Object]
[object Object]
[object Object]